Exploring the Knowledge and Perception of Generic Medicines among Final Year Undergraduate Medical, Pharmacy, and Nursing Students in Sierra Leone: A Comparative Cross-Sectional Approach. by James, PB et al.
pharmacy
Article
Exploring the Knowledge and Perception of Generic
Medicines among Final Year Undergraduate Medical,
Pharmacy, and Nursing Students in Sierra Leone:
A Comparative Cross-Sectional Approach
Peter Bai James 1,2 ID , Abdulai Jawo Bah 3, Emmanuel Kamanda Margao 1, Christian Hanson 4,
John Alimamy Kabba 5,6 ID and Shazia Qasim Jamshed 7,* ID
1 Faculty of Pharmaceutical Sciences, College of Medicine and Allied Health Sciences,
University of Sierra Leone, Freetown, Sierra Leone; jamepeb@yahoo.com (P.B.J.);
emmiks@yahoo.co.uk (E.K.M.)
2 Faculty of Health, University of Technology Sydney, Sydney 2007, Australia
3 Faculty of Basic Medical Sciences, College of Medicine and Allied Health Sciences,
University of Sierra Leone, Freetown, Sierra Leone; abdulaijawobah@yahoo.com
4 Pharmacy Board of Sierra Leone, Ministry of Health and Sanitation, New England Ville Freetown, Freetown,
Sierra Leone; chrisson2001@yahoo.com
5 Department of Pharmacy Administration and Clinical Pharmacy, Center for Drug Safety and Policy Research,
Xi’an Jiaotong University, Xi’an 710061, China
6 Directorate of Drugs and Medical Supplies, Ministry of Health and Sanitation, New England Ville Freetown,
Freetown, Sierra Leone; fudimamy@yahoo.com
7 Department of Pharmacy Practice, Kulliyyah of Pharmacy, International Islamic University Malaysia,
Kuantan 25200, Malaysia
* Correspondences: shazia_jamshed@iium.edu.my or pharmacist1992@live.com
Received: 12 October 2017; Accepted: 1 January 2018; Published: 4 January 2018
Abstract: Most low-income nations have national medicine policy that emphasized the use of
generic medicines in the public health sector. However, the use of generics is often debatable as
there are concerns over its efficacy, quality, and safety compared to their branded counterparts.
This study was conducted to compare the knowledge and perception of generic medicines among
final year undergraduate medical, pharmacy, and nursing students in Sierra Leone. We conducted
a questionnaire-based cross-sectional study among these students at the College of Medicine and
Allied Health Sciences University of Sierra Leone. Out of the 62 students, only two (2/62, 3.2%)
knew about the acceptable bioequivalence limit. At least half of respondents in all three groups
agreed that all generics are therapeutically equivalent to their innovator brand. At least half of the
medicine (21/42, 50%) and nursing (6/9, 66.6%) students, compared to pharmacy students (5/11,
45.5%), believed that higher safety standards are required for proprietary medicines than for generic
medicines. Most of them agreed that they need more information on the safety, quality, and efficacy
aspects of generics (59/62, 95.2%). All three groups of healthcare students, despite variations in their
responses, demonstrated a deficiency in knowledge and misconception regarding generic medicines.
Training on issues surrounding generic drugs in healthcare training institutions is highly needed
among future healthcare providers in Sierra Leone.
Keywords: generic medicines; knowledge; perception; medical students; pharmacy students; nursing
students; Sierra Leone
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1. Introduction
A huge proportion of health budget of most developing countries goes to purchasing drugs
needed to treat diseases of public health importance [1]. Therefore, access to treatment is challenged by
the availability of affordable medicines. One-third of the population in the developing world does not
have access to medicines [1]. Accessibility is often hampered, among others, by high prices of these
drugs [2]. As a strategy to increase access, most developed and developing countries have instituted
measures to reduce expenditure on medicines. One such approach involves promoting the use of
generic medicines among healthcare providers [3].
In Sierra Leone, even though there is no particular policy on generic substitution, the national
drug policy does state that all prescription and dispensing of medicines in the public sector should be
done using generics. The policy further states that the Ministry of Health and Sanitation (MOHS) will
promote generic prescribing and dispensing in the private sector [4]. However, the implementation
of such policy statements remains a challenge in promoting rational medicine use. With patient
out-of-pocket expenses accounting for 62% of healthcare costs [5], access to, and the utilization of,
health services including pharmaceuticals among the general population is still poor. On the other
hand, health service utilization including pharmaceuticals seems to have improved with the passage
of the free health care policy for pregnant women, lactating mothers, and children under five [6].
This initiative ensures that medicines prescribed and dispensed are from the essential drug list all
of which are listed by their generic names [7]. For example, 71% of medications prescribed for
children under five at the tertiary pediatric hospital were generics [8]. Despite such improvement,
anecdotal reports suggest that the use of generics is still a controversial issue among health care
providers as there is a huge concern over their efficacy, quality, and safety compared to their branded
counterparts. Similar misconceptions about generics were reported elsewhere among future health
care professionals [9,10].
Studies elsewhere have indicated that it is often a challenge to change perception as well as
the prescribing and dispensing behavior of healthcare providers about generics [11–13]. Therefore,
the need for education to change attitudes is required especially for future health care providers as their
current perception of generic medicine can impact their future prescribing and generic substitution
pattern. Such interventions have been recommended in the developed world and in some developing
countries as a way to promote the use of generics [14]. However, studies on knowledge and perception
of generic drugs among healthcare providers and students are few, especially in the African region.
Currently, the knowledge about and perception of generic medicines among health care providers
and students in Sierra Leone are unknown. To address this gap in knowledge, this study compares
the knowledge about and perception of generic medicines among final year medical, pharmacy,
and nursing students in Sierra Leone.
2. Materials and Methods
The present study was conducted among final year undergraduate medical, pharmacy,
and nursing students at College of Medicine and Allied Health Sciences University of Sierra Leone
(COMAHS-USL) using a cross-sectional study design. Sixty-eight final year students (46-medical,
11-pharmacy and 11-nursing) registered for the 2014/2015 academic year constituted the study
population. We conducted the study between June and August 2015. COMAHS-USL is the only tertiary
institution in Sierra Leone that offers undergraduate programs in medicine, pharmacy, and nursing [15].
The undergraduate medical and pharmacy programs have been in existence since the inception of
the college in 1988 while the nursing program started in 2005 when the national school of nursing
became part of COMAHS-USL [15]. The medicine, pharmacy, and nursing programs run for six,
five, and four years, respectively. Due to the stringent entry requirements and cost, admission rates
in to these programs are usually low. The current medicine, pharmacy, and nursing curricula do
offer an overview of generic bioequivalent and rational medicine use that is taught as part of the
general pharmacology module in the third professional year. This module has three contact hours per
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week and is taught for two months [16]. However, for pharmacy students, these topics continue to
be extensively covered in the fourth and final professional years under their clinical pharmacy and
pharmaceutics courses [16]. These courses have three contact hours per week and are taught for three
months [16]. We sought ethical approval from the COMAHS-USL Research and Ethics Committee
before the study commenced.
A validated questionnaire used in a Malaysian study [17] was used to collect data from participants
in this study. Some modifications were made to fit our local context. For example, the original
validated questionnaire asked respondents to indicate their ethnicity since Malaysia is host to different
ethnic groups. We decided to remove the question on ethnicity since Sierra Leone is homogeneous
with regard to ethnicity. The questionnaire consisted of three sections. The first section looked at
respondents’ demographics such age, sex, and course of study. The second section consisted of
13 items that attempt to assess students’ knowledge about generic and their branded name medicine,
12 of which were evaluated using a five-point Likert scale. The remaining item specifically asked
about the allowable regulatory bioequivalence limits that the Pharmacy Board of Sierra Leone (PBSL)
stipulates when comparing generic medicines and their branded counterparts. We included the
following statements to aid their understanding of what bioequivalence is: “In pharmacology, the term
bioavailability refers to how fast and how much a drug is absorbed and becomes available at the site
of the drug action”; “The PBSL requires that a generic medicine has a comparable bioavailability
to that of its proprietary counterpart.” The third section consisted of seven items that seek to
understand respondents’ perceptions about generic and brand medicines using five-point Likert
scale responses. Strongly agree, agree, neutral, disagree, and strongly disagree were considered as
point descriptors. Written consent was solicited after the rationale of the study was explained to
participants. Questionnaires were distributed to consenting students in their classes and returned
within 20–25 min to ensure a high response. Students were told that they were at liberty to opt out of
the study at any time while completing the questionnaire. They were also assured that they would
not be penalized whatsoever if they decide not to participate. It was also clearly stated on the consent
form that the questions asked were for research purpose only and it was not going to be part of any
assessment required for them to graduate. Students were not allowed to use any reference to answer
the questions. Paper-pencil format was used as the method for questionnaire administration. All filled
questionnaire were collected and checked for completeness.
Analysis of the data collected was done using SPSS version 16 (SPSS, Inc., Chicago, IL, USA).
Descriptive statistics were used to calculate frequency counts and percentages for respondent
demographic characteristics and Likert scale responses. Likert scale responses “strongly agree and
agree” were grouped as a positive response, while “strongly disagree and disagree” were grouped as a
negative response when interpreting the results. Associations between these dependent variables (all
knowledge and perception statements) and independent variable (program of study) were computed
using the Kruskal–Wallis test. This test was used due to the small size of the study population (n = 68)
and the skewness of the population in each cadre. An alpha value less than 0.05 was considered
statistically significant for differences observed among the three groups.
3. Results
3.1. Respondent Demographics
The overall response rate was 91.2% (62/68). Most of the students were male (62.9%), between
the age of 20–29 years, and from the faculty of medicine (Table 1).
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Table 1. Respondent demographics (n = 62).
Variables Frequency Percentages
Age Group 20–29 years 46 74.2








3.2. Knowledge of Regulatory Bioequivalence Limit among Final Year Undergraduate Medicine, Pharmacy,
and Nursing Student
On their knowledge of regulatory bioequivalence limit, students were asked to choose the correct
allowed bioequivalence limits when comparing a generic medicine with an innovator branded product.
Six options were presented from which they were asked to select the correct answer. The allowed
bioequivalence limit is 80–125%. We grouped their responses into three categories: “correct,”
“incorrect,” and “I do not know.” Based on their responses, only two students chose the correct
answer (2; 3.2%), while the rest either did not know (38; 61.3%) or chose the wrong answer (22; 35.5%).
To determine the association between the course of study and knowledge of bioequivalence limit,
the “I do not know” option was considered as an incorrect answer. The Kruskal–Wallis test showed
no statistically significant difference (p = 0.545) among the three groups of final year undergraduate
students with regard to their knowledge of the bioequivalence limit (Figure 1).
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Figure 1. Knowledge of regulatory bioequivalence limit among final year undergraduate medicine,
pharmacy, and nursing students. The Kruskal–Wallis test showed no statistically significant difference
(p = 0.545) among the three groups of final year undergraduate students.
3.3. Knowledge and Perceptions about Generic Equivalent According to Course of Study
At least half of the final year students in all of the three faculties agreed that generic products
of a particular medicine that are rated as generic equivalents are therapeutically equivalent to the
innovator brand product. Additionally, almost all students in all three faculties agreed that they need
more information on the conduct of bioequivalence tests. On the other hand, pharmacy (8/11, 72.8%)
and nursing (9/9, 100%) students were more likely than their medical counterparts (20/42, 47.6%) to
agree that generic products of a particular drug considered as generic equivalents are therapeutically
equivalent to each other (p = 0.002). The details are highlighted in Table 2.
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Table 2. Knowledge and perceptions about generic equivalent according to course of study.
Statements Program of Study SA n (%) A n (%) N n (%) D n (%) SD n (%) p-Value 1
All generic products of a particular medicine that are rated as
generic equivalents are therapeutically equivalent to the
innovator brand product
Medicine n = 42 2 (4.8) 21 (50.0) 10 (23.8) 8 (19.0) 1 (2.4)
0.056
Pharmacy n = 11 2 (18.2) 6 (54.5) 2 (18.2) 1 (9. 1) 0 (0.0)
Nursing n = 9 3 (33.3) 4 (44.4) 2 (22.2) 0 (0.0) 0 (0.0)
Total n (%) 7 (11.3) 31 (50.0) 14 (22.6) 9 (14.5) 1 (1.6)
All generic products of a particular medicine that are rated as
generic equivalents are therapeutically equivalent to
each other
Medicine n = 42 1 (2.4) 19 (45.2) 9 (21.4) 12 (28.6) 1 (2.4)
0.002
Pharmacy n = 11 3 (27.3) 5 (45.5) 1 (9.1) 2 (18.2) 0 (0.0)
Nursing n = 9 3 (33.3) 6 (66.7) 0 (0.0) 0 (0.0) 0 (0.0)
Total n (%) 7 (11.3) 30 (48.4) 10 (16.1) 14 (22.6) 1 (1.6)
I have not been introduced to the issues of bioequivalence for
generic drugs during my undergraduate education
Medicine n = 42 5 (11.9) 16 (38.1) 3 (7.1) 15 (35.7) 3 (7.1)
0.692
Pharmacy n = 11 0 (0.0) 4 (36.4) 2 (18.2) 4 (36.4) 1 (9.1)
Nursing n = 9 0 (0.0) 3 (33.3) 2 (22.2) 4 (44.4) 0 (0.0)
Total n (%) 5 (8.1) 23 (37.1) 7 (11.7) 23 (37.1) 4 (6.5)
I need more information on how bioequivalence tests are
conducted for generic medicines
Medicine n = 42 18 (42.9) 22 (52.4) 1 (2.4) 1 (2.4) 0 (0.0)
0.237
Pharmacy n = 11 3 (27.3) 7 (63.6) 1 (9.1) 0 (0.0) 0 (0.0)
Nursing n = 9 2 (22.2) 5 (55.6) 2 (22.2) 0 (0.0) 0 (0.0)
Total n (%) 23 (37.1) 34 (54.8) 4 (6.5) 1 (1.6) 0 (0.0)
SA = strongly agree; A= agree; n = neutral; D = disagree; SD = strongly disagree, 1 Kruskall–Wallis test.
Pharmacy 2018, 6, 3 6 of 12
3.4. Knowledge and Perceptions of the Quality, Safety, and Efficacy of Generic Medicines versus Brand Name
Drug According to Course of Study
With regard to quality, safety, and effectiveness of generic medicines compared to their branded
equivalents, pharmacy (6/11, 54.5%) and nursing (6/9, 66.6%) students were likely to agree compared
to their medical peers (13/42, 31.0%) that a generic medication is bioequivalent to its branded
counterpart (p = 0.015). On the other hand, medical (29/42, 69.1%) and pharmacy (11/11, 100%)
students were more likely to disagree than their nursing counterparts (5/9, 55.6%) that generic
medicines are less effective than their originator brand product (p = 0.049). Additionally, medical
(34/42, 81%) and pharmacy (9/11, 81.8%) students were more likely to disagree than nursing (2/9,
22.2%) students (p = 0.004) that generic medicines are of inferior quality to branded drugs. Surprisingly,
less than half of medical (18/42, 42.9%), pharmacy (2/11, 18.2%), and nursing (3/9, 33.3%) students
believed that generic medicines are less expensive than their branded counterparts. Although not
statistically significant, pharmacy students (8/11, 72.7%) compared to their medical (23/42, 54.8%) and
nursing (4/9, 44.4%) peers were against the notion that a generic medicine has more side effects than
their corresponding innovator product. Additionally, (21/42, 50%), (5/11, 45.5%), and (6/9, 66.6%) of
medical, pharmacy, and nursing students, respectively, agreed to a large extent that innovator brand
drugs are required to meet higher safety standards than generic medicines (Table 3).
3.5. The Perceptions of Students about Generic Medicines According to Course of Study
Table 4 shows responses of all three cadres of healthcare students with regard to their perception
of generic medicine. Based on their knowledge, medical and pharmacy students felt more comfortable
to provide advice in the future with regard to generics medicines than their nursing counterparts
(p < 0.001). Similarly, medical and pharmacy but nursing students were more likely to (p = 0.011) to
agree that they found it easier to remember a medicine’s therapeutic class using generic names than its
branded name. Additionally, medical and pharmacy students but nursing students believed that a
pharmacist is the most appropriate person to advice on generic medicines. All of them agreed that
they needed more information on issues about the safety and efficacy of generic medicines.
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Table 3. Knowledge and perceptions of the quality, safety, and efficacy of generic medicines versus brand name medicine according to course of study.
Statements Program of Study SA n (%) A n (%) N n (%) D n (%) SD n (%) p-Value 1
A generic medicine is bioequivalent to a brand
name medicine
Medicine n = 42 1 (2.4) 12 (28.6) 15 (35.7) 14 (33.3) 0 (0.0)
0.015
Pharmacy n = 11 1 (9.1) 5 (45.5) 3 (27.3) 2 (18.2) 0 (0.0)
Nursing n = 9 3 (33.3) 3 (33.3) 3 (33.3) 0 (0.0) 0 (0.0)
Total n (%) 5 (8.1) 20 (32.3) 21 (33.9) 16 (25.8) 0 (0.0)
A generic medicine must be in the same
dosage form (e.g., tablet, capsule) as the brand
name medicine
Medicine n = 42 4 (9.5) 20 (47.6) 5 (11.9) 13 (31.0) 0 (0.0)
0.211
Pharmacy n = 11 2 (18.2) 3 (27.3) 2 (18.2) 3 (27.3) 1 (9.1)
Nursing n = 9 1 (11.1) 7 (77.8) 1 (11.1) 0 (0.0) 0 (0.0)
Total n (%) 7 (11.3) 30 (48.4) 8 (12.9) 16 (25.8) 1 (1.6)
A generic medicine must contain the same
dose as the brand name medicine
Medicine n = 42 7 (16.7) 21 (50.0) 5 (11.9) 9 (21.4) 0 (0.0)
0.188
Pharmacy n = 11 3 (27.3) 6 (54.5) 1 (9.1) 1 (9.1) 0 (0.0)
Nursing n = 9 2 (22.2) 7 (77.8) 0 0 (0.0) 0 (0.0)
Total n (%) 12 (19.4) 34 (54.8) 6 (9.7) 10 (16.1) 0 (0.0)
Generic medicines are of inferior quality to
branded drugs
Medicine n = 42 0 (0.0) 3 (7.1) 5 (11.9) 28 (66.7) 6 (14.3)
0.004
Pharmacy n = 11 0 (0.0) 0 (0.0) 2 (18.2) 6 (54.5) 3 (27.3)
Nursing n = 9 0 (0.0) 1 (11.1) 6 (66.7) 2 (22.2) 0 (0.0)
Total n (%) 0 (0.0) 4 (6.5) 13 (21.0) 36 (58.1) 9 (14.5)
Generic medicines are less effective than brand
name medicines
Medicine n = 42 2 (4.8) 7 (16.7) 4 (9..5) 23 (54.8) 6 (14.3)
0.049
Pharmacy n = 11 0 (0.0) 0 (0.0) 0 (0.0) 8 (72.7) 3 (27.3)
Nursing n = 9 0 (0.0) 1 (11.1) 3 (33.3) 5 (55.6) 0 (0.0)
Total n (%) 2 (3.2) 8 (12.9) 7 (11.3) 36 (58.1) 9 (14.5)
Generic medicines are less safe than brand
name medicines
Medicine n = 42 2 (4.8) 6 (14.3) 11 (26.2) 17 (40.5) 6 (14.3)
0.562
Pharmacy n = 11 0 (0.0) 0 (0.0) 3 (27.3) 8 (72.7) 0 (0.0)
Nursing n = 9 0 (0.0) 1 (11.2) 4 (44.4) 4 (44.4) 0 (0.0)
Total n (%) 2 (3.2) 7 (11.3) 18 (29.0) 29 (46.8) 6 (9.7)
Generic medicines are less expensive than
brand name medicines
Medicine n = 42 7 (16.7) 11 (26.2) 15 (35.7) 6 (14.3) 3 (7.1)
0.330
Pharmacy n = 11 2 (18.2) 0 (0.0) 5 (45.5) 3 (27.2) 1 (9.1)
Nursing n = 9 0 (0.0) 3 (33.3) 2 (22.2) 4 (44.4) 0 (0.0)
Total n (%) 9 (14.5) 14 (22.6) 22 (35.5) 13 (21.0) 4 (6.5)
Brand name medicines are required to meet
higher safety standards than generic medicines
Medicine n = 42 6 (14.3) 15 (35.7) 13 (31.0) 7 (16.7) 1 (2.4)
0.193
Pharmacy n = 11 0 5 (45.5) 3 (27.2) 3 (27.2) 0 (0.0)
Nursing n = 9 3 (33.3) 3 (33.3) 3 (33.3) 0 (0.0) 0 (0.0)
Total n (%) 9 (14.5) 23 (37.1) 19 (30.6) 10 (16.1) 1 (1.6)
SA = strongly agree; A= agree; N = neutral; D = disagree; SD = strongly disagree, 1 Kruskall–Wallis test.
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Table 4. The perceptions of students about generic medicines according to course of study.
Statements Program of Study SA n (%) A n (%) N n (%) D n (%) SD n (%) p-Value 1
From the knowledge I have, I’m confident in giving advice
in the future by generic drug name rather than brand name
Medicine n = 42 9 (21.4) 27 (64.3) 4 (9.5) 2 (4.8) 0 (0.0)
<0.001
Pharmacy n = 11 0 (0.0) 6 (54.5) 3 (27.3) 2 (18.2) 0 (0.0)
Nursing n = 9 0 (0.0) 0 (0.0) 6 (66.7) 3 (33.3) 0 (0.0)
Total n (%) 9 (14.5) 33 (53.2) 13 (21.0) 7 (11.3) 0 (0.0)
I find it easier to recall a medicine’s therapeutic class using
generic names rather than brand names
Medicine n = 42 20 (47.6) 17 (40.5) 2 (4.8) 3 (7.1) 0 (0.0)
0.011
Pharmacy n = 11 3 (27.3) 5 (45.5) 2 (18.2) 1 (9.1) 0 (0.0)
Nursing n = 9 0 (0.0) 5 (55.6) 3 (33.3) 1 (11.1) 0 (0.0)
Total n (%) 23 (37.1) 27 (43.5) 7 (11.3) 5 (8.1) 0 (0.0)
I believe that pharmacists are one of the most important
health care professionals to give advice on generic
medicines
Medicine n = 42 25 (59.5) 16 (38.1) 0 (0.0) 1 (2.4) 0 (0.0)
<0.001
Pharmacy n = 11 7 (63.6) 4 (36.4) 0 (0.0) 0 (0.0) 0 (0.0)
Nursing n = 9 1 (11.1) 2 (22.2) 0 (0.0) 4 (44.4) 2 (22.2)
Total n (%) 33 (53.2) 22 (35.5) 0 (0.0) 5 (8.1) 2 (3.2)
I believe that multinational products are of good quality
than local company products
Medicine n = 42 8 (19.0) 18 (42.9) 12 (28.6) 2 (4.8) 2 (4.8)
0.282
Pharmacy n = 11 2 (18.2) 4 (36.4) 4 (36.4) 1 (9.1) 0 (0.0)
Nursing n = 9 0 (0.0) 3 (33.3) 5 (55.6) 1 (11.1) 0 (0.0)
Total n (%) 10 (16.1) 25 (40.3) 21 (33.9) 4 (6.5) 2 (3.2)
I need more information on the issues pertaining to the
safety and efficacy of generic medicines
Medicine n = 42 17 (40.5) 22 (52.4) 1 (2.4) 1 (2.4) 1 (2.4)
0.764
Pharmacy n = 11 3 (27.3) 8 (72.7) 0 (0.0) 0 (0.0) 0 (0.0)
Nursing n = 9 2 (22.2) 7 (77.8) 0 (0.0) 0 (0.0) 0 (0.0)
Total n (%) 22 (35.5) 37 (59.7) 1 (1.6) 1 (1.6) 1 (1.6)
I believe my health training should include course on
rational medicine use
Medicine n = 42 23 (54.7) 17 (40.5) 1 (2.4) 0 (0.0) 1 (2.4)
0.110
Pharmacy n = 11 6 (54,5) 5 (45.5) 0 (0.0) 0 (0.0) 0 (0.0)
Nursing n = 9 2 (22.2) 5 (55.6) 2 (22.2) 0 (0.0) 0 (0.0)
Total n (%) 31 (50.0) 27 (43.5) 3 (4.8) 0 (0.0) 1 (1.6)
I believe my health training should include course on
national drug policy and essential drug list
Medicine n = 42 28 (66.7) 13 (30.9) 0 (0.0) 0 (0.0) 1 (2.4)
0.208
Pharmacy n = 11 6 (54,5) 5 (45.5) 0 (0.0) 0 (0.0) 0 (0.0)
Nursing n = 9 3 (33.3) 6 (66.7) 0 (0.0) 0 (0.0) 0 (0.0)
Total n (%) 37 (59.7) 24 (38.7) 0 (0.0) 0 (0.0) 1 (1.6)
SA = strongly agree; A= agree; N = neutral; D = disagree; SD = strongly disagree, 1 Kruskall–Wallis test.
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4. Discussion
The issue surrounding generic medicine use is of public health importance especially in
developing countries where public access to essential medicines for common diseases is often
hampered by the escalating cost of medication especially branded products [2]. The successful
implementation of the generic medicine substitution policy in many countries around the world hinges
on healthcare providers’ knowledge and perception of generic medicines [18]. Such an informed view
will influence physician, pharmacist prescribing, and dispensing patterns, respectively. Our study
results have identified a gap in knowledge and misconceptions about generics among these cohorts of
future healthcare providers. It is hoped that our result will provide an opportunity for implementing
educational interventions that address such knowledge deficit and misunderstanding about generic
medications. Additionally, our findings will help inform the design of future generic medicine policy,
regulations, and practice as well as direct the future research agenda with regard to generic medicine
use in Sierra Leone.
The knowledge of the allowable regulatory bioequivalence limit among future healthcare
professionals has been poor. The current research finding in this regard is not an exception as merely a
couple of students chose the correct answer. This finding is in concordance with previously published
studies in Australia, Nepal, Bangladesh, and Aruba [10,13,19,20]. This knowledge deficit exhibited by
medical and nursing students was not surprising, as they are less likely to be exposed to the topics such
as biopharmaceutics since their curricula are devoid of such a course [16]. However, it was surprising,
even though it has been reported elsewhere [17], to learn that pharmacy students equally lack such
knowledge given that they are expected to be educated on such a topic since it is part of their curriculum.
A study in Yemen among pre-registration pharmacists indicated that they fully understood the concept
of bioequivalence even with little exposure during their undergraduate training [21]. However, their
overwhelming endorsement that they need more information on bioequivalence testing of generic
medicines shows that the majority of medicine, pharmacy, and nursing students lack knowledge
on bioequivalence of generic medicines and are unaware of the regulatory requirements for generic
medicines approval in Sierra Leone. Such an observation may be explained in that, the concept
of bioequivalence testing and the criteria for generic medicine approval in Sierra Leone are not
part of the medicine and nursing curricula [16]. With regard to pharmacy students, it is possible
that they might have been educated on the topic but with limited scope, or they might have failed
to fully fathom the perceived difficult concepts of bioavailability and bioequivalence during their
pharmacokinetics and pharmaceutics courses [22]. Either way, an introduction to such an important
concept especially in medical and nursing curricula and proper teaching of such an important subject
in the pharmacy program will help to address the observed knowledge gap. Improving these future
healthcare providers’ knowledge on bioequivalence and bioequivalence testing of generic medicines
will help boost their confidence in prescribing and dispensing generic medicines in the future.
Students from all three groups agreed that all generic products of a particular drug referred to
as generic equivalents are therapeutically equivalent to their innovator brand. A similar picture was
reported by Hassali and colleagues [10]. On the other hand, our respondents agreed that generic
equivalents of a particular innovator brand are therapeutically equivalent to each other. Our result
does not correlate with what was reported in an Australian study where the majority of respondents
disagreed that generic drugs considered as generic equivalents are therapeutically equivalents [10].
This difference is likely linked to the difference in regulatory policy regarding generic equivalents and
its innovator brand. The drug registration guideline of the Pharmacy Board of Sierra Leone failed to
state whether generics equivalents of a particular originator product should be therapeutically equal
to each other. Instead, it states that data demonstrating that a generic medicine is bioequivalent to its
innovator counterparts should be provided for market authorization of that a particular generic drug
to be granted [23]. In Table 3, we observed that pharmacy students followed by nursing students were
likely to believe, more than their medical counterparts, that a generic medicine and its corresponding
innovator brand are bioequivalent to each other. This observed variation in perception among the three
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groups of students is likely linked to the difference in curricula. Subjects such as pharmaceutics that are
extensively covered are not part of the current nursing and medical curricula at COMAHS-USL [16].
Regarding the safety quality and efficacy of generic medicines compared to their corresponding
originator branded counterparts, pharmacy and medical students tend to have a better understanding
compared to their nursing colleagues. For example, the majority of pharmacy and medical students
compared to their nursing counterparts were against the notion that a generic drug is less effective
and of low quality than its innovator product. On safety, a conflicting view was observed. On the one
hand, most students in all three cadres (with nursing being the least) disagreed that generic medicines
are less safe than their corresponding innovator brands. On the other hand, slightly more than half of
the total respondents from all three groups (with nursing and pharmacy being the highest and least
respectively) agreed that innovator brand name medicines require higher safety standards than their
generic counterparts. Our result to a larger extent mirrors the result of a similar study conducted
in Australia on medical and pharmacy students’ perception of efficacy quality and safety of generic
medicines and their innovator brands [10]. However, it contrasts with studies done in Bangladesh [13]
and Nigeria [11] in which pharmacy students considered generic medicines to be of low quality and
less effective. This difference in views indicates that none of the group particularly medical and
nursing cohorts had a clear understanding of the quality, efficacy, and safety requirements for generic
medicines compared to their innovator brands in Sierra Leone [23]. It is also possible that variation in
packaging and presentation may have influenced their varied perceptions. The negative perception of
generic medicines especially among medicine and nursing students may lead to low faith in the use of
generic medicines. For medical students, such a low confidence may negatively influence their future
prescribing behavior of generic medicines if an educational intervention to change perception is not
implemented. Thus, improving their knowledge through training will not only have a positive impact
on the future prescribing and dispensing behavior but will also positively influence how these future
healthcare providers educate their patients with regard to the use of generic medicines.
At most one-third (with pharmacy students being the least) agreed that generic medicines are
less expensive than their branded name products. An appreciable number were not sure or chose
to disagree. This is in sharp contrast to findings reported in Australia [10] and between pharmacy
students in public and private universities in Pakistan in which the majority subscribed to the fact
that generics are much cheaper than their branded counterparts [17]. The difference in view may be a
function of their limited knowledge and misconception of issues surrounding generic medicines. This is
primarily linked to little exposure to courses about generic medicines during their undergraduate
training [16]. Additionally, their misconceptions that generic medicines are expensive compared to
their innovator brands may be due to their inability to distinguish between certain generic medicines
and their originator brands. The prices of certain generic medicines especially in the private sector are
not regulated. Private drug companies solely set prices, and this may fluctuate based on the demand
and supply of these products. The current national medicine policy is devoid of a specific policy
statement on generic medicines including their pricing. It only encourages the use of generics in all
public health facilities [4]. The overwhelming agreement by all final year undergraduate students in
the three faculties that they needed more information on the quality and safety of generic medicines
and that their healthcare training should include courses on national drug policy, essential medicine
lists, and rational medicine use is a confirmation of their deficiency in knowledge and misconceptions
about generic medicines. The use of an audio–visual educational package advocated in a Malaysian
study [24] is also recommended to be adopted in the healthcare training institutions of Sierra Leone,
as it is expected to critically appraise students about generics and their promotion in professional
practice. Other educational interventions could include an interactive lecture that specifically covers
topics such as bioequivalence, regulatory requirements for market authorization of generic medicine
in Sierra Leone, generic medicine facts, and the promotion of rational prescribing and dispensing
using generic medicines [25]. The distribution of reference materials to students such as a booklet
that contains basic facts about generic medicines as well as a list of the generic names of commonly
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prescribed and dispensed medicines is also an educational intervention that helps improve knowledge
among students [25].
A possible limitation of this study is the tendency for social desirability bias since questionnaires
were self-administered. We also cannot exclude the possibility that participants might have discussed
responses among themselves even though they were asked to answer the questions independently.
Nevertheless, the major strength of this study is its high response rate, therefore, the conclusion derived
from the study represents the views of final year undergraduate medicine, pharmacy, and nursing
students in Sierra Leone. COMAHS-USL is the only tertiary healthcare training institution that offers
undergraduate medicine, pharmacy, and nursing degree programs in Sierra Leone [26].
5. Conclusions
All three cadres of healthcare students, despite differences in responses, showed limited knowledge
and misconceptions about generic medicines. In-depth training programs on issues surrounding generic
drugs need to be designed and implemented by educators at COMAHS-USL.
Acknowledgments: We want to thank the final year medical, pharmacy, and nursing students who agreed to
participate in the in the study. We will also like to extend our gratitude to the deans of the various faculties for
creating the enabling environment for data collection.
Author Contributions: P.B.J. conceptualized the study, contributed to its design, data collection, analyzed and
interpreted the data, and wrote the draft manuscript. S.Q.J. contributed to study design as well as data analysis
and interpretation and substantially contributed to the intellectual content of the manuscript. A.J.B. contributed to
study design, data collection, and intellectual content of the manuscript. E.K.M., C.H., and J.A.K. contributed to
study design and literature review and helped review the manuscript. All authors read and approved the final
version of the manuscript.
Conflicts of Interest: The authors declare no conflict of interest.
Abbreviations
PBSL Pharmacy Board of Sierra Leone
COMAHS-USL College of Medicine and Allied Health Sciences, University of Sierra Leone
References
1. Lu, Y.; Hernandez, P.; Abegunde, D.; Edejer, T. The World Medicines Situation 2011. Medicine Expenditures;
World Health Organization: Geneva, Switzerland, 2011.
2. Hogerzeil, H.V.; Mirza, Z. The World Medicines Situation 2011: Access to Essential Medicines as Part of the Right
to Health; World Health Organization: Geneva, Switzerland, 2011; pp. 680–689.
3. Cameron, A.; Mantel-Teeuwisse, A.K.; Leufkens, H.G.M.; Laing, R.O. Switching from originator brand
medicines to generic equivalents in selected developing countries: How much could be saved? Value Health
2012, 15, 664–673. [CrossRef] [PubMed]
4. Ministry of Health and Sanitation Sierra Leone. National Medicine Policy Ministry of Health and Sanitation
Freetown; Ministry of Health and Sanitation Sierra Leone: Freetown, Sierra Leone, 2012.
5. WHO. Global Health Expenditure Database; World Health Organisation: Geneva, Switzerland, 2014.
6. Witter, S.; Brikci, N.; Harris, T.; Williams, R.; Keen, S.; Mujica, A.; Jones, A.; Murray-Zmijewski, A.; Bale, B.;
Leigh, B. The Sierra Leone Free Health Care Initiative (FHCI): Process and Effectiveness Review. 2016.
Available online: http://eresearch.qmu.ac.uk/4358/1/eResearch%204358.pdf (accessed on 24 August 2017).
7. Government of Sierra Leone. National Essential Medicine List; Ministry of Health and Sanitation Freetown:
Freetown, Sierra Leone, 2012.
8. Cole, C.P.; James, P.B.; Kargbo, A.T. An evaluation of the prescribing patterns for under-five patients at a
tertiary paediatric hospital in Sierra Leone. J Basic Clin. Pharm. 2015, 6, 109–114. [CrossRef] [PubMed]
9. Chua, G.N.; Hassali, M.A.; Shafie, A.A.; Awaisu, A. A survey exploring knowledge and perceptions of
general practitioners towards the use of generic medicines in the northern state of Malaysia. Health Policy
2010, 95, 229–235. [CrossRef] [PubMed]
Pharmacy 2018, 6, 3 12 of 12
10. Hassali, M.A.; Kong, D.; Stewart, K. A comparison between senior medical students’ and pharmacy
pre-registrants’ knowledge and perceptions of generic medicines. Med. Educ. 2007, 41, 703–710. [CrossRef]
[PubMed]
11. Auta, A.; Bala, E.T.; Shalkur, D. Generic medicine substitution: A cross-sectional survey of the perception of
pharmacists in North-Central, Nigeria. Med. Princ. Pract. 2014, 23, 53–58. [CrossRef] [PubMed]
12. Hassali, M.A.; Shafie, A.A.; Awaisu, A.; Ibrahim, M.I.; Ping, C.C.; Jamshed, S. Physicians’ views on generic
medicines: A narrative review. J. Generic Med. 2010, 7, 30–39. [CrossRef]
13. Siam, M.K.S.; Khan, A.; Khan, T.M. Medical and pharmacy students’ knowledge and perceptions about
generic medicines in Bangladesh. J. Pharm. Health Serv. Res. 2013, 4, 57–61. [CrossRef]
14. Patel, A.; Gauld, R.; Norris, P.; Rades, T. Quality of generic medicines in South Africa: Perceptions versus
reality—A qualitative study. BMC Health Serv. Res. 2012, 12, 297. [CrossRef] [PubMed]
15. University of Sierra Leone. College of Medicine and Allied Health Sciences. Available online: http://www.
usl.edu.sl/?page_id=786 (accessed on 17 May 2017).
16. College of Medicine and Allied Health Sciences University of Sierra Leone. Revised Curriculum for the Bachelor
of Medicine and Pharmacy Programs; University of Sierra Leone: Freetown, Sierra Leone, 2014.
17. Jamshed, S.Q.; Ibrahim, M.I.M.; Hassali, M.A.; Sharrad, A.K.; Shafie, A.A.; Babar, Z.-U.-D. Understanding
and perceptions of final-year doctor of pharmacy students about generic medicines in Karachi, Pakistan:
A quantitative insight. Adv. Med. Educ. Pract. 2015, 6, 359–366. [CrossRef] [PubMed]
18. Hassali, M.A.; Alrasheedy, A.A.; McLachlan, A.; Nguyen, T.A.; AL-Tamimi, S.K.; Ibrahim, M.I.M.;
Aljadhey, H. The experiences of implementing generic medicine policy in eight countries: A review and
recommendations for a successful promotion of generic medicine use. Saudi Pharm. J. 2014, 22, 491–503.
[CrossRef] [PubMed]
19. Gyawali, S.; Hassali, M.A.; Saha, A. A survey exploring the knowledge and perceptions of senior medical
students in Nepal toward generic medicines. SAGE Open Med. 2016, 4, 2050312116662570. [CrossRef]
[PubMed]
20. Shankar, P.R.; Herz, B.L.; Dubey, A.K.; Hassali, M.A. Assessment of knowledge and perceptions toward
generic medicines among basic science undergraduate medical students at Aruba. Indian J. Pharmacol. 2016,
48, S29–S32. [CrossRef] [PubMed]
21. Othman, G.Q.; Abdulghani, M.A. Assessment of knowledge and perceptions of generic medicines among
pharmacy students in Yemeni universities. Pharm. Educ. 2015, 15, 93–98.
22. Hassali, M.A.; Kong, D.C.; Stewart, K. Knowledge and perceptions of recent pharmacy graduates about
generic medicines. Pharm. Educ. 2007, 7, 89–95. [CrossRef]
23. Pharmacy Board of Sierra Leone. Guidlines for Registration Medicinal Product Freetown; Pharmacy Board of
Sierra Leone: Freetown, Sierra Leone, 2014.
24. Lee, S.W.; Hassali, M.A.; Shafie, A.A. Knowledge and perception of senior year pharmacy students about
generic medicines in public universities of Malaysia. Arch. Pharm. Pract. 2014, 5, 108–112. [CrossRef]
25. Hassali, M.A.; Wong, Z.Y.; Alrasheedy, A.A.; Saleem, F.; Mohamad Yahaya, A.H.; Aljadhey, H. Does
educational intervention improve doctors’ knowledge and perceptions of generic medicines and their
generic prescribing rate? A study from Malaysia. SAGE Open Med. 2014, 2, 2050312114555722. [CrossRef]
[PubMed]
26. Smith, A.E. The Founding Of a Medical College: Overcoming Obstacles to Academic Development in Sierra
Leone. Res. Sierra Leone Stud. (RISLS) Weave 2013, 1, 2.
© 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution
(CC BY) license (http://creativecommons.org/licenses/by/4.0/).
